Cargando…
GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains
The occurrence of anti-drug antibodies following administration of therapeutic monoclonal antibody to patients is a growing problem that is attracting attention from frontline clinicians. Ideally, an initial indicative point of care test would provide guidance to seek testing approved by the regulat...
Autores principales: | Saxena, Gauri K., Theocharopoulos, Ioannis, Aziz, Nisha Thaslima, Jones, Meleri, Gnanapavan, Sharmilee, Giovannoni, Gavin, Schmierer, Klaus, Garnett, James A., Baker, David, Kang, Angray S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002611/ https://www.ncbi.nlm.nih.gov/pubmed/32024871 http://dx.doi.org/10.1038/s41598-020-58041-3 |
Ejemplares similares
-
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab
por: Ali, Liaqat, et al.
Publicado: (2020) -
The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies
por: Baker, David, et al.
Publicado: (2020) -
Detecting and predicting neutralization of alemtuzumab responses in MS
por: Saxena, Gauri, et al.
Publicado: (2020) -
Guinea pig immunoglobulin VH and VL naïve repertoire analysis
por: Matsuzawa, Shun, et al.
Publicado: (2018) -
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
por: Baker, David, et al.
Publicado: (2020)